Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice
about
Anticoagulation for the prevention of stroke in non-valvular AF in general practice: room for improvement.Clinical Prediction Model for Time in Therapeutic Range While on Warfarin in Newly Diagnosed Atrial Fibrillation.Role of rivaroxaban in the management of atrial fibrillation: insights from clinical practice.
P2860
Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Stroke and Bleeding Risk Assoc ...... rillation in Clinical Practice
@ast
Stroke and Bleeding Risk Assoc ...... rillation in Clinical Practice
@en
type
label
Stroke and Bleeding Risk Assoc ...... rillation in Clinical Practice
@ast
Stroke and Bleeding Risk Assoc ...... rillation in Clinical Practice
@en
prefLabel
Stroke and Bleeding Risk Assoc ...... rillation in Clinical Practice
@ast
Stroke and Bleeding Risk Assoc ...... rillation in Clinical Practice
@en
P2093
P2860
P356
P1476
Stroke and Bleeding Risk Assoc ...... rillation in Clinical Practice
@en
P2093
Amanda Bruno
Brian Meissner
Daniel T Lang
Diana G Dills
Gustavus Aranda
Kristin P Jazdzewski
Nazia Rashid
P2860
P356
10.1161/JAHA.115.001921
P577
2015-07-17T00:00:00Z